Related Experiment Video
Updated: Apr 27, 2026

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
Current therapeutic options in hairy cell leukemia
Evgeny Mikler1, John Mascarenhas
1Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
Hairy cell leukemia (HCL) is a B-cell cancer requiring treatment for symptomatic patients. Advances have improved diagnosis and management, with options including chemotherapy, immunotherapy, and surgery.
Area of Science:
- Hematology
- Oncology
Background:
- Hairy cell leukemia (HCL) is a rare B-cell chronic lymphoproliferative disorder.
- It presents with monocytopenia, organomegaly, constitutional symptoms, and bone marrow fibrosis.
Purpose of the Study:
- To summarize the diagnostic and management advances in HCL over the past 55 years.
- To outline the indications for treatment and available therapeutic options.
Main Methods:
- Review of literature on Hairy cell leukemia diagnosis and treatment.
- Analysis of clinical characteristics and therapeutic outcomes.
Main Results:
- Significant progress has been made in HCL diagnosis and management.
- Treatment is indicated for symptomatic patients or those with bone marrow failure or infections.
- Asymptomatic patients without cytopenias may be observed.
Conclusions:
- Hairy cell leukemia, while indolent, often requires intervention.
- Therapeutic strategies encompass chemotherapy, immunotherapy, biological agents, and surgery.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)